TNL-ULTRA ASSAY FOR THE ADVIA CENTAUR SYSTEM

Immunoassay Method, Troponin Subunit

BAYER HEALTHCARE, LLC

The following data is part of a premarket notification filed by Bayer Healthcare, Llc with the FDA for Tnl-ultra Assay For The Advia Centaur System.

Pre-market Notification Details

Device IDK053020
510k NumberK053020
Device Name:TNL-ULTRA ASSAY FOR THE ADVIA CENTAUR SYSTEM
ClassificationImmunoassay Method, Troponin Subunit
Applicant BAYER HEALTHCARE, LLC 511 BENEDICT AVE. Tarrytown,  NY  10591
ContactAndres Holle
CorrespondentAndres Holle
BAYER HEALTHCARE, LLC 511 BENEDICT AVE. Tarrytown,  NY  10591
Product CodeMMI  
CFR Regulation Number862.1215 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2005-10-26
Decision Date2005-12-30
Summary:summary

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
00630414600109 K053020 000
00630414600093 K053020 000
00630414516226 K053020 000
00630414516219 K053020 000
00630414293790 K053020 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.